Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Open Study, Exploratory Examination of Efficacy and Safety of Paricalcitol Injection and Maxacalcitol Injection in Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism

NCT00990704 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00990704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00990704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Open Study, Exploratory Examination of Efficacy and Safety of Paricalcitol Injection and Maxacalcitol Injection in Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism
Lead sponsor
Abbott
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2009
Completion date
May 31, 2010
Enrollment
47 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis, secondary hyperparathyroidism